IND: (+91) 949418 5556
sales@envisioninteligence.com
- Home
- Industry Reports
- 3D Bioprinting Market – Size, Share, Trends, Growth, Forecast (2023 – 2030)
Introduction:
3D bio printing is a medical application of 3D printers, and this technique involves an array of 3D printing methods to combine cells and biomaterials to produce biomedical parts. During the process of 3D bioprinting, the cell function and viability of the output construct is preserved, which can be used for R&D in various medical areas. 3D bioprinting is mainly engaged for developing organ and tissue constructs, which can be used for R&D of drugs, scaffolds, and development of medical implants.
Global 3D Bioprinting Market Size & Growth:
The global 3D bio printing market was valued at $XX Billion in 2018 and is estimated to reach $XX Billion by 2026, growing at a CAGR of around 26.5% during the forecast period. Factors such as increasing use of 3D bio printing in the drug discovery process, technological advancements for manufacturing customized products, and high demand for organ transplantation are responsible for the market growth during the forecast period. Rise in public and private funding to support 3D bioprinting research activities is also a major factor contributing to the market growth. Despite these drivers, the major restraints hampering the market growth include lack of complete automation, high initial costs, and dearth of trained professionals. Growing awareness related to 3D bio printing and increasing stem cell research, and high usage of 3D printing in cosmetic surgeries are driving the market towards greater opportunities during the forecast period.
Global 3D Bioprinting Market Segments:
The global 3D bioprinting market is segregated based on material, technology, application, end-user, and geography. By material, the market is categorized into hydrogels, extracellular matrices, living cells, and others. The living cells segment is estimated to account the largest market share during the forecast period, due to rising R&D initiatives. The hydrogels segment is projected to register the highest CAGR during the forecast period.
By technology, the magnetic levitation segment is estimated to witness the fastest growth rate during the forecast period, owing to wide application area and increase in adoption of the technique by innovators. Moreover, inkjet 3D bioprinting segment holds the largest market share, due to its low cost and versatility.
By application, the research applications segment holds the largest share in the market. The segment growth is mainly attributed by the factors such as increasing initiatives by market players and university scientists in 3D bioprinting.
By end-user, the pharmaceutical segment shows the significant market growth in the overall market. The pharmaceutical industry is expected to grow multi-fold, thereby increasing the demand for medical pills.
By geography, the market is categorized into North America, South America, Asia Pacific, Europe, and Middle East & Africa. Among all these, North America region is projected to be the dominant regional market during the forecast period. Increasing target population base, presence of well-established companies and sophisticated healthcare infrastructure along with high disposable income levels in the region are expected to propel the market growth. Furthermore, extensive research activities conducted within the region are said to contribute to the market expansion.
Asia Pacific region is projected to grow with the highest CAGR during the forecast period, due to increase in overall and stem cell research activity, high demand for organ transplantation, and growing initiatives by key players.
Global 3D Bioprinting Market Trends:
- In October 2018, the U.S. FDA awarded a grant of $2.5 million to top five research institutions for R&D in bio-manufacturing, including 3D bioprinting.
- China introduced “Made in China 2025” initiative to foster advanced technology in the 3D printing space.
- In February 2018, 3D Systems introduced NextDent 5100, a Figure 4-based 3D bioprinter designed for dental labs. NextDent 5100 facilitates high-speed 3D bioprinting to produce dental appliances and sacrificial castings.
- In January 2019, The Institute for Technology Inspired Regenerative Medicine in Netherlands collaborated with Aspect Biosystems, a Canadian company, for the advancements in 3D printing and regenerative medicine.
Global 3D Bioprinting Market Research Report Include:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
- Expertise investment opportunities by analyst to the individual and organization to have better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Organovo Holdings, Inc.
- Cellink AB.
- Bio3D Technologies.
- Aspect Bio Systems Ltd.
- Stratasys Ltd.
- Materialise NV.
Along with these companies, there were many other companies considered/ cited in the report while analyzing the 3D bioprinting market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. other players have considerable presence owing to its robust brand image, geographical reach, and strong customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising incidence of chronic diseases & geriatric population
4.1.2. Technological advancements for manufacturing customized products
4.1.3. High demand for organ transplantation
4.1.4. Rise in public and private funding to support 3D bio printing research activities
4.2. Market Restraints & Challenges
4.2.1. Lack of complete automation
4.2.2. Dearth of trained professionals and high initial costs
4.3. Market Opportunities
4.3.1. Growing awareness related to 3D bio printing
4.3.2. Increasing stem cell research
4.3.3. High usage of 3D printing in cosmetic surgeries
CHAPTER 5 GLOBAL 3D BIOPRINTING MARKET – BY MATERIAL
5.1. Introduction
5.2. Hydrogels
5.3. Extracellular matrices
5.4. Living cells
5.5. Other biomaterials
CHAPTER 6 GLOBAL 3D BIOPRINTING MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. Micro extrusion bio printing
6.3. Inkjet 3D bio printing
6.4. Laser-assisted bio printing
6.5. Magnetic 3D bio printing
6.6. Others (Syringe-based 3D Bio printing and Pneumatic Extrusion-based 3D Bio printing)
CHAPTER 7 GLOBAL 3D BIOPRINTING MARKET – BY APPLICATION
7.1. Introduction
7.2. Research
7.3. Drug Testing & Development
7.4. Regenerative Medicine
7.5. Food Testing
7.6. Others
CHAPTER 8 GLOBAL 3D BIOPRINTING MARKET – BY END-USER
8.1. Pharmaceutical & Biotechnology Companies
8.2. Research Organizations
8.3. Academic Institutions
CHAPTER 9 GLOBAL 3D BIOPRINTING MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL 3D BIOPRINTING MARKET – COMPANY PROFILES
10.1. Organovo Holdings, Inc.
10.2. Cellink AB.
10.3. Bio3D Technologies.
10.4. Aspect Bio Systems Ltd.
10.5. Stratasys Ltd.
10.6. Materialise NV.
10.7. ENVISIONTEC, INC.
10.8. Nano3D Biosciences, Inc.
10.9. Cyfuse Biomedical K.K.
10.10. 3Dynamic Systems Ltd.
10.11. Regenhu SA,
10.12. Cayman Chemical Company
10.13. GFS Chemicals, Inc.
10.14. Chiron As.
CHAPTER 11 GLOBAL 3D BIOPRINTING MARKET – COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Global Report
$2,700.00 – $8,100.00
- EUR: €2,535.93 - €7,607.78
- INR: ₹223,915.89 - ₹671,747.68
- AED: د.إ9,909.00 - د.إ29,727.00
- GBP: £2,201.06 - £6,603.17
Additional information
| Report Type | Extensive Report, Miniature report, Snapshot Report |
|---|---|
| Licence | Single User License, Team License, Corporate License |
Introduction:
3D bio printing is a medical application of 3D printers, and this technique involves an array of 3D printing methods to combine cells and biomaterials to produce biomedical parts. During the process of 3D bioprinting, the cell function and viability of the output construct is preserved, which can be used for R&D in various medical areas. 3D bioprinting is mainly engaged for developing organ and tissue constructs, which can be used for R&D of drugs, scaffolds, and development of medical implants.
Global 3D Bioprinting Market Size & Growth:
The global 3D bio printing market was valued at $XX Billion in 2018 and is estimated to reach $XX Billion by 2026, growing at a CAGR of around 26.5% during the forecast period. Factors such as increasing use of 3D bio printing in the drug discovery process, technological advancements for manufacturing customized products, and high demand for organ transplantation are responsible for the market growth during the forecast period. Rise in public and private funding to support 3D bioprinting research activities is also a major factor contributing to the market growth. Despite these drivers, the major restraints hampering the market growth include lack of complete automation, high initial costs, and dearth of trained professionals. Growing awareness related to 3D bio printing and increasing stem cell research, and high usage of 3D printing in cosmetic surgeries are driving the market towards greater opportunities during the forecast period.
Global 3D Bioprinting Market Segments:
The global 3D bioprinting market is segregated based on material, technology, application, end-user, and geography. By material, the market is categorized into hydrogels, extracellular matrices, living cells, and others. The living cells segment is estimated to account the largest market share during the forecast period, due to rising R&D initiatives. The hydrogels segment is projected to register the highest CAGR during the forecast period.
By technology, the magnetic levitation segment is estimated to witness the fastest growth rate during the forecast period, owing to wide application area and increase in adoption of the technique by innovators. Moreover, inkjet 3D bioprinting segment holds the largest market share, due to its low cost and versatility.
By application, the research applications segment holds the largest share in the market. The segment growth is mainly attributed by the factors such as increasing initiatives by market players and university scientists in 3D bioprinting.
By end-user, the pharmaceutical segment shows the significant market growth in the overall market. The pharmaceutical industry is expected to grow multi-fold, thereby increasing the demand for medical pills.
By geography, the market is categorized into North America, South America, Asia Pacific, Europe, and Middle East & Africa. Among all these, North America region is projected to be the dominant regional market during the forecast period. Increasing target population base, presence of well-established companies and sophisticated healthcare infrastructure along with high disposable income levels in the region are expected to propel the market growth. Furthermore, extensive research activities conducted within the region are said to contribute to the market expansion.
Asia Pacific region is projected to grow with the highest CAGR during the forecast period, due to increase in overall and stem cell research activity, high demand for organ transplantation, and growing initiatives by key players.
Global 3D Bioprinting Market Trends:
- In October 2018, the U.S. FDA awarded a grant of $2.5 million to top five research institutions for R&D in bio-manufacturing, including 3D bioprinting.
- China introduced “Made in China 2025” initiative to foster advanced technology in the 3D printing space.
- In February 2018, 3D Systems introduced NextDent 5100, a Figure 4-based 3D bioprinter designed for dental labs. NextDent 5100 facilitates high-speed 3D bioprinting to produce dental appliances and sacrificial castings.
- In January 2019, The Institute for Technology Inspired Regenerative Medicine in Netherlands collaborated with Aspect Biosystems, a Canadian company, for the advancements in 3D printing and regenerative medicine.
Global 3D Bioprinting Market Research Report Include:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analyzed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial analysis with major competitors.
- Expertise investment opportunities by analyst to the individual and organization to have better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as
- Organovo Holdings, Inc.
- Cellink AB.
- Bio3D Technologies.
- Aspect Bio Systems Ltd.
- Stratasys Ltd.
- Materialise NV.
Along with these companies, there were many other companies considered/ cited in the report while analyzing the 3D bioprinting market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. other players have considerable presence owing to its robust brand image, geographical reach, and strong customer base.
CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter’s Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising incidence of chronic diseases & geriatric population
4.1.2. Technological advancements for manufacturing customized products
4.1.3. High demand for organ transplantation
4.1.4. Rise in public and private funding to support 3D bio printing research activities
4.2. Market Restraints & Challenges
4.2.1. Lack of complete automation
4.2.2. Dearth of trained professionals and high initial costs
4.3. Market Opportunities
4.3.1. Growing awareness related to 3D bio printing
4.3.2. Increasing stem cell research
4.3.3. High usage of 3D printing in cosmetic surgeries
CHAPTER 5 GLOBAL 3D BIOPRINTING MARKET – BY MATERIAL
5.1. Introduction
5.2. Hydrogels
5.3. Extracellular matrices
5.4. Living cells
5.5. Other biomaterials
CHAPTER 6 GLOBAL 3D BIOPRINTING MARKET – BY TECHNOLOGY
6.1. Introduction
6.2. Micro extrusion bio printing
6.3. Inkjet 3D bio printing
6.4. Laser-assisted bio printing
6.5. Magnetic 3D bio printing
6.6. Others (Syringe-based 3D Bio printing and Pneumatic Extrusion-based 3D Bio printing)
CHAPTER 7 GLOBAL 3D BIOPRINTING MARKET – BY APPLICATION
7.1. Introduction
7.2. Research
7.3. Drug Testing & Development
7.4. Regenerative Medicine
7.5. Food Testing
7.6. Others
CHAPTER 8 GLOBAL 3D BIOPRINTING MARKET – BY END-USER
8.1. Pharmaceutical & Biotechnology Companies
8.2. Research Organizations
8.3. Academic Institutions
CHAPTER 9 GLOBAL 3D BIOPRINTING MARKET – BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL 3D BIOPRINTING MARKET – COMPANY PROFILES
10.1. Organovo Holdings, Inc.
10.2. Cellink AB.
10.3. Bio3D Technologies.
10.4. Aspect Bio Systems Ltd.
10.5. Stratasys Ltd.
10.6. Materialise NV.
10.7. ENVISIONTEC, INC.
10.8. Nano3D Biosciences, Inc.
10.9. Cyfuse Biomedical K.K.
10.10. 3Dynamic Systems Ltd.
10.11. Regenhu SA,
10.12. Cayman Chemical Company
10.13. GFS Chemicals, Inc.
10.14. Chiron As.
CHAPTER 11 GLOBAL 3D BIOPRINTING MARKET – COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.
Related Products
